FY2026 Earnings Estimate for Quipt Home Medical Corp. (NASDAQ:QIPT) Issued By Leede Financial

Quipt Home Medical Corp. (NASDAQ:QIPT) – Stock analysts at Leede Financial upped their FY2026 earnings per share estimates for Quipt Home Medical in a research note issued on Thursday, August 15th. Leede Financial analyst D. Loe now expects that the company will post earnings of $0.04 per share for the year, up from their prior estimate of $0.03.

Quipt Home Medical (NASDAQ:QIPT) last posted its quarterly earnings results on Wednesday, August 14th. The company reported ($0.04) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.01 by ($0.05). The firm had revenue of $63.97 million for the quarter, compared to analyst estimates of $65.03 million. Quipt Home Medical had a negative net margin of 1.71% and a negative return on equity of 3.89%. During the same period in the prior year, the company posted ($0.03) earnings per share.

A number of other research firms have also recently issued reports on QIPT. Ventum Cap Mkts upgraded Quipt Home Medical to a “strong-buy” rating in a research note on Tuesday, July 16th. Raymond James cut shares of Quipt Home Medical from a “market perform” rating to an “underperform” rating and cut their price objective for the company from $10.00 to $2.50 in a research note on Friday, May 17th. Eight Capital upgraded Quipt Home Medical to a “strong-buy” rating in a report on Friday, May 17th. Benchmark dropped their price target on Quipt Home Medical from $10.00 to $9.00 and set a “buy” rating on the stock in a report on Monday, May 20th. Finally, Stifel Nicolaus decreased their price target on Quipt Home Medical from $10.50 to $9.50 and set a “buy” rating for the company in a research report on Friday, May 17th. One research analyst has rated the stock with a sell rating, three have given a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Quipt Home Medical presently has an average rating of “Buy” and an average target price of $6.75.

Quipt Home Medical Stock Performance

Quipt Home Medical stock traded up $0.12 during mid-day trading on Friday, reaching $2.86. The company’s stock had a trading volume of 82,094 shares, compared to its average volume of 191,849. The company has a current ratio of 1.14, a quick ratio of 0.79 and a debt-to-equity ratio of 0.66. The firm has a market cap of $121.76 million, a price-to-earnings ratio of -27.80 and a beta of 0.64. Quipt Home Medical has a twelve month low of $2.72 and a twelve month high of $6.01. The business has a 50 day moving average price of $3.31 and a 200-day moving average price of $3.78.

Institutional Investors Weigh In On Quipt Home Medical

Several institutional investors have recently made changes to their positions in the company. Price T Rowe Associates Inc. MD lifted its holdings in shares of Quipt Home Medical by 25.9% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 12,829 shares of the company’s stock valued at $57,000 after buying an additional 2,640 shares during the last quarter. Tower Research Capital LLC TRC lifted its holdings in shares of Quipt Home Medical by 141.3% during the 4th quarter. Tower Research Capital LLC TRC now owns 6,755 shares of the company’s stock valued at $34,000 after buying an additional 3,956 shares during the last quarter. Hsbc Holdings PLC lifted its holdings in shares of Quipt Home Medical by 10.4% during the 2nd quarter. Hsbc Holdings PLC now owns 52,522 shares of the company’s stock valued at $165,000 after buying an additional 4,969 shares during the last quarter. Bridge City Capital LLC lifted its holdings in shares of Quipt Home Medical by 17.9% during the 1st quarter. Bridge City Capital LLC now owns 47,721 shares of the company’s stock valued at $209,000 after buying an additional 7,244 shares during the last quarter. Finally, Rhumbline Advisers lifted its holdings in shares of Quipt Home Medical by 21.0% during the 2nd quarter. Rhumbline Advisers now owns 49,276 shares of the company’s stock valued at $159,000 after buying an additional 8,541 shares during the last quarter. 42.85% of the stock is currently owned by institutional investors and hedge funds.

About Quipt Home Medical

Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment.